These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10504699)

  • 1. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment.
    Birchler M; Viti F; Zardi L; Spiess B; Neri D
    Nat Biotechnol; 1999 Oct; 17(10):984-8. PubMed ID: 10504699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.
    Nilsson F; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2001 Jan; 61(2):711-6. PubMed ID: 11212273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Kaspar M; Trachsel E; Neri D
    Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors.
    Birchler MT; Milisavlijevic D; Pfaltz M; Neri D; Odermatt B; Schmid S; Stoeckli SJ
    Laryngoscope; 2003 Jul; 113(7):1231-7. PubMed ID: 12838025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.
    Neri D; Carnemolla B; Nissim A; Leprini A; Querzè G; Balza E; Pini A; Tarli L; Halin C; Neri P; Zardi L; Winter G
    Nat Biotechnol; 1997 Nov; 15(12):1271-5. PubMed ID: 9359110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antibodies for the selective targeting of tumor neovasculature.
    Viti F; Giovannoni L; Neri D
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):204-13. PubMed ID: 11926127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
    Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
    Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
    Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA
    Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
    Moosmayer D; Berndorff D; Chang CH; Sharkey RM; Rother A; Borkowski S; Rossi EA; McBride WJ; Cardillo TM; Goldenberg DM; Dinkelborg LM
    Clin Cancer Res; 2006 Sep; 12(18):5587-95. PubMed ID: 17000696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.
    Birchler M; Neri G; Tarli L; Halin C; Viti F; Neri D
    J Immunol Methods; 1999 Dec; 231(1-2):239-48. PubMed ID: 10648941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin.
    Demartis S; Tarli L; Borsi L; Zardi L; Neri D
    Eur J Nucl Med; 2001 Apr; 28(4):534-9. PubMed ID: 11357506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular neovascularization: a valuable model system.
    Campochiaro PA; Hackett SF
    Oncogene; 2003 Sep; 22(42):6537-48. PubMed ID: 14528278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
    Berndorff D; Borkowski S; Sieger S; Rother A; Friebe M; Viti F; Hilger CS; Cyr JE; Dinkelborg LM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7053s-7063s. PubMed ID: 16203802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of murine phage antibody library and selection of ricin-specific single-chain antibodies.
    Gao X; Huang Y; Zhu S
    IUBMB Life; 1999 Nov; 48(5):513-7. PubMed ID: 10637767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain.
    Carnemolla B; Neri D; Castellani P; Leprini A; Neri G; Pini A; Winter G; Zardi L
    Int J Cancer; 1996 Nov; 68(3):397-405. PubMed ID: 8903484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.
    Fabbrini M; Trachsel E; Soldani P; Bindi S; Alessi P; Bracci L; Kosmehl H; Zardi L; Neri D; Neri P
    Int J Cancer; 2006 Apr; 118(7):1805-13. PubMed ID: 16217760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.